Home / Market News / $TPST
fiscal.ai Corporate Catalyst Impact 55/100 ● neutral

Tempest Therapeutics Schedules Q3 2026 Earnings Announcement

Nov 5, 2026, 2:32 PM UTC · Primary ticker $TPST

This 8-K filing announces Tempest Therapeutics' Q3 2026 earnings release date and time, along with analyst consensus EPS estimates. While the announcement itself is routine, the upcoming earnings report will be a key event for investors to assess the company's financial performance against expectations.

This 8-K filing is a routine announcement by Tempest Therapeutics (TPST) regarding the scheduling of its third-quarter 2026 earnings release. The company will report its financial results on November 11, 2026, before market open, with analysts expecting an EPS of ($0.32). While the announcement itself is not market-moving, the actual earnings report will be a significant event for TPST investors. The short-term implication is that traders will be anticipating the earnings call, and the stock's price could see volatility around that date depending on whether the company beats, meets, or misses analyst expectations. Long-term implications depend entirely on the content of the earnings report and any forward guidance provided, which could impact investor sentiment and future valuations. The key opportunity for traders lies in anticipating the market's reaction to the actual earnings figures and any accompanying corporate updates.

$TPST neutral Primary subject of earnings announcement
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.